Cipher Pharmaceuticals (CPH) Stock Forecast & Price Target

C$16.52

+0.37 (+2.29%)

(As of 10/25/2024 ET)

Cipher Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 4 Analyst Ratings

Sell
0

Hold
1

Buy
3

Based on 4 Wall Street analysts who have issued ratings for Cipher Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Buy." Out of the 4 analysts, 1 has given a hold rating, 2 have given a buy rating, and 1 has given a strong buy rating for CPH.

Consensus Price Target

C$13.50
-18.28% Downside

According to the 4 analysts' twelve-month price targets for Cipher Pharmaceuticals, the average price target is C$13.50. The highest price target for CPH is C$19.00, while the lowest price target for CPH is C$8.00. The average price target represents a forecasted downside of -18.28% from the current price of C$16.52.

Get the Latest News and Ratings for CPH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cipher Pharmaceuticals and its competitors.

CPH Analyst Ratings Over Time

Type	Current Forecast 10/26/23 to 10/25/24	1 Month Ago 9/26/23 to 9/25/24	3 Months Ago 7/28/23 to 7/27/24	1 Year Ago 10/26/22 to 10/26/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	C$13.50	C$13.50	C$13.50	C$13.50
Forecasted Upside	-18.28% Downside	-18.28% Downside	-18.28% Downside	-18.28% Downside
Consensus Rating	Buy	Buy	Buy	Buy

War on Elon Escalates… (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

CPH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CPH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cipher Pharmaceuticals Stock vs. The Competition

Type	Cipher Pharmaceuticals	Medical Companies
Consensus Rating Score	3.00	2.79
Consensus Rating	Buy	Moderate Buy
News Sentiment Rating	Positive News See Recent CPH News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/24/2024	Stifel Nicolaus 4 of 5 stars		Boost Target		C$17.00 ➝ C$19.00	+17.28%
9/13/2024	Leede Financial 0 of 5 stars	D. Loe Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/12/2024	Stifel Canada 0 of 5 stars	J. Keywood Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
2/14/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Speculative Buy ➝ Buy	C$4.75 ➝ C$8.00	+13.96%
3/17/2023	Leede Jones Gab Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Loe Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:05 AM ET.

CPH Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Cipher Pharmaceuticals is C$13.50, with a high forecast of C$19.00 and a low forecast of C$8.00.
: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cipher Pharmaceuticals in the last year. There is currently 1 hold rating, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CPH shares.
: According to analysts, Cipher Pharmaceuticals's stock has a predicted downside of -18.28% based on their 12-month stock forecasts.
: Over the previous 90 days, Cipher Pharmaceuticals's stock had 2 upgrades and 1 downgrade by analysts.
: Cipher Pharmaceuticals has been rated by research analysts at Leede Financial, Stifel Canada, and Stifel Nicolaus in the past 90 days.
: Analysts like Cipher Pharmaceuticals more than other "medical" companies. The consensus rating for Cipher Pharmaceuticals is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CPH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Watch this before it gets removed (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

This page (TSE:CPH) was last updated on 10/25/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cipher Pharmaceuticals (CPH) Stock Forecast & Price Target